The BioNTech SE ADR BNTX slid 2.22% to $106.32 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.29% to 5,983.99 and Dow Jones ...
The company's platform integrates clinical and molecular data into personalized treatment plans for patients. The company has ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
GlobalData on MSN16h
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccineThe FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...
News Medical on MSN23h
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in children. Study: Multisystem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback